AV Laboratories Launches with New Product Duo

AV Laboratories, a clinical skin care brand that provides biotech innovations, has launched with two products: face serum and face cream light.

Created by a global team of chemists and molecular biologists, AV Laboratories is led by CEO and co-founder Ami Mezezi; co-founder and advisory board chairwoman Monica Mezezi; and co-developer and chief operating officer Sylwia Pawlaczyk. Years in the making with an R&D team in Europe, AV Laboratories said it emerged with a mission to harness years of stem cell research and apply it to the skin.

With over five years in development and testing, the AVL SOM3 is a biotech innovation that builds a scientifically optimized environment proven to nourish skin, said the company. All formulations work with skin to target specific concerns, such as the appearance of fine lines, wrinkles, dark spots, dryness and redness.

Face Serum

Face Serum ($195) is clinically proven to provide instant hydration, boost moisture and reduce the appearance of fine lines and wrinkles. Powered by patented AVL SOM3 technology, it contains 16 active ingredients, including argireline, ferulic acid and vitamin E. In a 28-day clinical trial, 100% of participants observed firmer skin and 96% agreed it reduced the appearance of fine lines and wrinkles.

Face Cream Light

Face Cream Light ($158) is clinically proven to hydrate and enhance skin barrier function. Formulated with AVL SOM3, the Face Cream Light comprises a blend of complexion-boosting essentials including niacinamide, bifida ferment lysate, antioxidant-rich persea gratissima oil and pyrus malus seed oil. Face Cream Light works to prevent the appearance of fine lines, wrinkles and hyperpigmentation while improving tone and smoothing skin texture.

Face serum and face cream light are available on avlaboratories.com.